|
Volumn 38, Issue 7, 2006, Pages 2138-2140
|
Successful Treatment of Hepatitis B Virus Infection With Lamivudine After Heart Transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIBODY;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
ADULT;
ARTICLE;
B CELL LYMPHOMA;
BILIRUBIN BLOOD LEVEL;
CARDIAC GRAFT REJECTION;
CLINICAL ARTICLE;
DISEASE EXACERBATION;
DNA DETERMINATION;
DNA VIRUS;
DRUG EFFICACY;
FEMALE;
HEART TRANSPLANTATION;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
LEUKOPENIA;
LIVER CIRRHOSIS;
LIVER FUNCTION TEST;
MALE;
MORBIDITY;
MORTALITY;
POLYMERASE CHAIN REACTION;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
TAIWAN;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VIRUS INFECTION;
VIRUS MUTANT;
ADULT;
ANTIVIRAL AGENTS;
FEMALE;
FOLLOW-UP STUDIES;
HEART TRANSPLANTATION;
HEPATITIS B;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS C;
HUMANS;
LAMIVUDINE;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 33846083332
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2006.06.011 Document Type: Article |
Times cited : (7)
|
References (8)
|